CASI Pharmaceuticals Inc
NASDAQ:CASI
| Market Cap (Intraday) | 21.23M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.38 |
| 50-Day MA | $1.68 |
| 200-Day MA | $3.06 |
CASI Pharmaceuticals Inc Stock, NASDAQ:CASI
1701-1702, China Central Office, Tower 1, No. 81 Jianguo Road, Beijing, Beijing 100025
Phone: +86.10.6508.6063
Number of Employees: 243
Description
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing innovative therapeutics and pharmaceutical products. The firm is also involved in developing innovative therapeutics addressing cancer and other unmet medical needs for the global market. The company was founded in 1991 and is headquartered in Beijing, China.